Extended Investigation of Exposure to Respirable Synthetic Amorphous Silica Dust and Its Potential Impact on Non-malignant Respiratory Morbidity

ObjectivesThe present analysis aims to study the health impact of an occupational exposure to respirable synthetic amorphous silica (SAS) dusts, based on the available data from the German study. MethodsThe effect of cumulative exposure to respirable SAS dust on respiratory morbidity were investigated in 462 exposed male workers. Multiple exposure assessments was performed anchored by a most recent measurement series. Internal regression models in addition to Monte Carlo-Multi Model were fitted. ResultsAn averaged cumulative respirable SAS dust concentration of 6.44 mg/m(3)-years was estimated. Internal regression models suggested a reduction of 8.11 ml (95% confidence interval: 0.49-15.73) in forced vital capacity (FVC) per 1 mg/m(3)-year increase of exposure. But no effect on forced expiratory volume in 1 s (FEV1) and the ratio of the parameters FEV1/FVC was observed in association with exposure to a respirable fraction of SAS. No adverse effects on the occurrence of respiratory diseases were indicated. ConclusionThis study provides no clear evidence of adverse health effects from occupational exposure to respirable SAS. SponsorEvonik Operations GmbH/Smart Materials, Cabot Corporation, Wacker Chemie AG.

Automated summary

The present study aims to investigate the health impact of occupational exposure to respirable synthetic amorphous silica (SAS) dusts. The results suggest a slight effect on lung function but no adverse effects on respiratory diseases.